Literature DB >> 19747506

Fatal co-infection with swine origin influenza virus A/H1N1 and community-acquired methicillin-resistant Staphylococcus aureus.

Vincent C C Cheng1, Yuk-Kong Lau, Kwok-Lun Lee, Kwan-Ho Yiu, Kwok-Hung Chan, Pak-Leung Ho, Kwok-Yung Yuen.   

Abstract

Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) co-infection has been described previously in association with respiratory tract infection caused by seasonal influenza A viruses, but not with swine origin influenza A (H1N1) virus (S-OIV). We report the clinical and pathological findings of the first death with fulminant co-infection by CA-MRSA. Since early empirical treatment with beta-lactam plus fluoroquinolone or macrolides is often initiated before specimen collections, bacterial co-infection in S-OIV may have been under-reported.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19747506     DOI: 10.1016/j.jinf.2009.08.021

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  14 in total

1.  Influenza virus primes mice for pneumonia from Staphylococcus aureus.

Authors:  Amy R Iverson; Kelli L Boyd; Julie L McAuley; Lisa R Plano; Mark E Hart; Jonathan A McCullers
Journal:  J Infect Dis       Date:  2011-01-28       Impact factor: 5.226

2.  Molecular characterization of methicillin-resistant Staphylococcus aureus with emergence of epidemic clones of sequence type (ST) 22 and ST 772 in Mumbai, India.

Authors:  Namita D'Souza; Camilla Rodrigues; Ajita Mehta
Journal:  J Clin Microbiol       Date:  2010-03-29       Impact factor: 5.948

3.  Hypercytokinemia with 2009 pandemic H1N1 (pH1N1) influenza successfully treated with polymyxin B-immobilized fiber column hemoperfusion.

Authors:  Shinhiro Takeda; Ryo Munakata; Shinji Abe; Seiji Mii; Manabu Suzuki; Takeru Kashiwada; Arata Azuma; Takeshi Yamamoto; Akihiko Gemma; Keiji Tanaka
Journal:  Intensive Care Med       Date:  2010-03-12       Impact factor: 17.440

Review 4.  Two years after pandemic influenza A/2009/H1N1: what have we learned?

Authors:  Vincent C C Cheng; Kelvin K W To; Herman Tse; Ivan F N Hung; Kwok-Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

5.  Pandemic and post-pandemic influenza A (H1N1) infection in critically ill patients.

Authors:  Ignacio Martin-Loeches; Emili Díaz; Loreto Vidaur; Antoni Torres; Cesar Laborda; Rosa Granada; Juan Bonastre; Mar Martín; Josu Insausti; Angel Arenzana; Jose Eugenio Guerrero; Ines Navarrete; Jesus Bermejo-Martin; David Suarez; Alejandro Rodriguez
Journal:  Crit Care       Date:  2011-11-28       Impact factor: 9.097

6.  Clinical and epidemiological characteristics of pandemic influenza A/(H1N1) in hospitalized pediatric patients at a university hospital, Istanbul, Turkey.

Authors:  Selda Hancerli Torun; Ayper Somer; Nuran Salman; Meral Ciblak; Demet Demirkol; Melis Kanturvardar; Selim Badur; Ömer Devecioğlu
Journal:  J Trop Pediatr       Date:  2010-09-05       Impact factor: 1.165

Review 7.  Swine Influenza (H1N1) pneumonia: clinical considerations.

Authors:  Burke A Cunha
Journal:  Infect Dis Clin North Am       Date:  2010-03       Impact factor: 5.982

8.  Community-acquired pneumonia due to pandemic A(H1N1)2009 influenzavirus and methicillin resistant Staphylococcus aureus co-infection.

Authors:  Ronan J Murray; James O Robinson; Jodi N White; Frank Hughes; Geoffrey W Coombs; Julie C Pearson; Hui-Leen Tan; Glenys Chidlow; Simon Williams; Keryn J Christiansen; David W Smith
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

Review 9.  Viral pathogens and acute lung injury: investigations inspired by the SARS epidemic and the 2009 H1N1 influenza pandemic.

Authors:  Carolyn M Hendrickson; Michael A Matthay
Journal:  Semin Respir Crit Care Med       Date:  2013-08-11       Impact factor: 3.119

10.  Rapidly Progressive Multiple Cavity Formation in Necrotizing Pneumonia Caused by Community-acquired Methicillin-resistant Staphylococcus aureus Positive for the Panton-Valentine Leucocidin Gene.

Authors:  Yuki Takigawa; Keiichi Fujiwara; Takashi Saito; Takamasa Nakasuka; Taichi Ozeki; Sachi Okawa; Kenji Takada; Yoshitaka Iwamoto; Hiroe Kayatani; Daisuke Minami; Ken Sato; Miki Nagao; Takuo Shibayama
Journal:  Intern Med       Date:  2018-10-17       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.